Genotropin Therapy in GH-Deficient Men with CAD: 3-Year RCT on CV Parameters
Reading Time: < 1 minuteIntroduction Coronary artery disease (CAD) remains the leading cause of morbidity and mortality among American males, with over 10 million diagnosed cases annually according to the American Heart Association. Growth hormone (GH) deficiency, often comorbid in aging populations, exacerbates cardiovascular risk through adverse effects on lipid metabolism, endothelial function, and myocardial contractility. Genotropin®, a recombinant human growth hormone (rhGH), has... Read more »
